Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 7Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Hypoparathyroidism 2Carcinoma, Squamous Cell 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Diseases 1Recurrence 1Rectal Neoplasms 1Parathyroid Diseases 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Melanoma 1Margins of Excision 1Lymphedema 1Head and Neck Carcinoma 1Graves Disease 1Goiter 1Endometrial Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1Adenoma 1

Interventions

Standard of Care 5Practice Guidelines as Topic 5Magnetic Resonance Spectroscopy 2pembrolizumab 1X-Rays 1Surgery, Computer-Assisted 1Solutions 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Neurofeedback 1Monitoring, Physiologic 1Interviews as Topic 1Indocyanine Green 1Docetaxel 1DEAE-Dextran 1Counseling 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Carcinoma × Indocyanine Green × Head & Neck × Clear all
NCT03745690 2022-03-17

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Withdrawn
Head & Neck

Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡